DrugPatentWatch Database Preview
Details for Patent: 8,231,885
Which drugs does patent 8,231,885 protect, and when does it expire?
Patent 8,231,885 protects MIRVASO and is included in one NDA.
This patent has seventy-seven patent family members in twenty-four countries.
Summary for Patent: 8,231,885
| Title: | Compounds, formulations, and methods for ameliorating telangiectasis |
| Abstract: | Methods, compounds, and topical formulations for treatment of telangiectasias are disclosed. The methods comprise topically applying a composition comprising an .alpha.-adrenergic receptor agonist to telangiectatic skin. Amelioration of telangiectasia symptoms begins within minutes after topical application of a disclosed composition. A single application can significantly lessen telangiectasia discoloration for at least about 2 hours. |
| Inventor(s): | DeJovin; Jack A. (New Brunswick, NJ), DeJovin; Isabelle Jean (New Brunswick, NJ) |
| Assignee: | Galderma Laboratories Inc. (Fort Worth, TX) |
| Application Number: | 12/544,663 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,231,885 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; Formulation; |
Drugs Protected by US Patent 8,231,885
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | MIRVASO | brimonidine tartrate | GEL;TOPICAL | 204708-001 | Aug 23, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,231,885
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 530185 | Start Trial | |||
| Australia | 2004242967 | Start Trial | |||
| Australia | 2005247467 | Start Trial | |||
| Australia | 2011231543 | Start Trial | |||
| Brazil | 112012024289 | Start Trial | |||
| Brazil | PI0511519 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
